Form 4: Oncology Institute CFO Sells Shares to Cover Tax Obligations
SEC Form 4 Filing
Robert Ross Carter, CFO of Oncology Institute, Inc., sold 1,601 shares of Class A Common Stock to cover tax withholding obligations related to vesting restricted stock units.
Summary
- Robert Ross Carter, the Chief Financial Officer of Oncology Institute, Inc. (TOI), reported a transaction on May 21, 2025.
- Carter sold 1,601 shares of Class A Common Stock at a price of $2.675 per share.
- The sale was executed to cover tax withholding obligations related to the vesting of restricted stock units (RSUs).
- Following the transaction, Carter directly owns 235,174 shares of Class A Common Stock.
Sentiment
Score: 6
Explanation: The sentiment is neutral as the transaction is a routine sale to cover tax obligations, with no indication of positive or negative implications for the company's performance.
Industry Context
Sales of shares to cover tax obligations upon vesting of restricted stock units are a common practice among corporate executives. This transaction reflects a standard procedure for managing equity compensation and does not necessarily indicate a change in the executive's confidence in the company.
Key Dates
| Date | Description |
|---|---|
| 05/21/2025 | Date of transaction: CFO Robert Ross Carter sold shares. |
| 05/22/2025 | Date of signature by Attorney-in-fact for Robert Carter. |
Keywords
Form 4, Oncology Institute, TOI, Robert Ross Carter, CFO, stock sale, restricted stock units, tax withholding
Disclaimer:The information provided here is for general informational purposes only and does not constitute financial advice, recommendation, or endorsement of any kind. It may contain errors or omissions. You should not rely on this information to make financial decisions. Always seek the advice of a qualified financial professional before making any investment or financial decisions. Use of this information is at your own risk.